Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Zentalis Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
120
−16 vs. Q3 2023
Shares held
81.1M
+2.97M (+3.8%) vs. Q3 2023
Total value
$1.23B
−$338.4M (−21.6%) vs. Q3 2023
New holders
20
44 more added
Sold out
36
33 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 120 institutions
Q1 2021: 95 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 139 institutionsQ1 2022: 128 institutionsQ2 2022: 122 institutionsQ3 2022: 121 institutionsQ4 2022: 106 institutionsQ1 2023: 110 institutionsQ2 2023: 134 institutionsQ3 2023: 137 institutionsQ4 2023: 120 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 136 institutionsQ4 2024: 142 institutionsQ1 2025: 132 institutionsQ2 2025: 117 institutionsQ3 2025: 99 institutionsQ4 2025: 86 institutionsQ1 2026: 102 institutionsQ2 2026: 114 institutions
Value heldQ4 2023: $1.23B
Q1 2021: $1.58BQ2 2021: $2.13BQ3 2021: $2.75BQ4 2021: $3.61BQ1 2022: $2.05BQ2 2022: $1.64BQ3 2022: $1.27BQ4 2022: $1.30BQ1 2023: $1.15BQ2 2023: $2.32BQ3 2023: $1.61BQ4 2023: $1.23BQ1 2024: $1.34BQ2 2024: $314.3MQ3 2024: $261.2MQ4 2024: $195.2MQ1 2025: $92.9MQ2 2025: $64.5MQ3 2025: $79.7MQ4 2025: $54.9MQ1 2026: $101.7MQ2 2026: $228.9M
Institutions holding ZNTL and their total value by quarter
QuarterHoldersValue
Q2 2026114$228.9M
Q1 2026102$101.7M
Q4 202586$54.9M
Q3 202599$79.7M
Q2 2025117$64.5M
Q1 2025132$92.9M
Q4 2024142$195.2M
Q3 2024136$261.2M
Q2 2024145$314.3M
Q1 2024142$1.34B
Q4 2023120$1.23B
Q3 2023137$1.61B
Q2 2023134$2.32B
Q1 2023110$1.15B
Q4 2022106$1.30B
Q3 2022121$1.27B
Q2 2022122$1.64B
Q1 2022128$2.05B
Q4 2021139$3.61B
Q3 2021116$2.75B
Q2 2021120$2.13B
Q1 202195$1.58B

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q3 2023.

Institutions holding ZNTL in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Ameritas Investment Partners, Inc.5,837$88.4K0.00%00.0%Unchanged
Great West Life Assurance Co5,018$76.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,615$54.8K0.00%+2,589+252.3%Added
Metropolitan Life Insurance Co3,388$51.3K0.00%00.0%Unchanged
Quest Partners LLC2,482$37.6K0.01%+2,482New
EverSource Wealth Advisors, LLC1,045$15.8K0.00%+904+641.1%Added
Cutler Group LP900$13.0K0.00%00.0%Unchanged
US Bancorp658$9.97K0.00%−229−25.8%Reduced
Advisor Group Holdings, Inc.651$9.86K0.00%−643−49.7%Reduced
Nisa Investment Advisors, LLC565$8.56K0.00%00.0%Unchanged
Daiwa Securities Group Inc.212$3.00K0.00%00.0%Unchanged
HighMark Wealth Management LLC130$1.97K0.00%00.0%Unchanged
UBS Group AG110$1.67K0.00%−66,723−99.8%Reduced
Proequities, Inc.100$1.51K0.00%00.0%Unchanged
Arlington Trust Co LLC70$1.06K0.00%+70New
Signaturefd, LLC30$4550.00%−21−41.2%Reduced
FinTrust Capital Advisors, LLC17$2530.00%00.0%Unchanged
GAMMA Investing LLC19$2250.00%+19New
Farther Finance Advisors, LLC10$1520.00%+10New
Covestor Ltd4$00.00%−1−20.0%Reduced
Avidity Partners Management LP0$00.00%−2,100,000−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−1,211,641−100.0%Sold out
First Light Asset Management, LLC0$00.00%−848,477−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−700,000−100.0%Sold out
Capital World Investors0$00.00%−683,000−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−301,667−100.0%Sold out
Ameriprise Financial Inc0$00.00%−166,004−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−156,475−100.0%Sold out
Twinbeech Capital LP0$00.00%−128,859−100.0%Sold out
Two Sigma Investments, LP0$00.00%−109,429−100.0%Sold out
Ghost Tree Capital, LLC0$00.00%−100,000−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−99,412−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−87,640−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−47,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−45,473−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−37,439−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−35,225−100.0%Sold out
Trexquant Investment LP0$00.00%−24,516−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−24,344−100.0%Sold out
Engineers Gate Manager LP0$00.00%−22,611−100.0%Sold out
XTX Topco Ltd0$00.00%−19,008−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−18,800−100.0%Sold out
Virtu Financial LLC0$00.00%−16,223−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−14,900−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−10,600−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−10,190−100.0%Sold out
GTS Securities LLC0$00.00%−9,987−100.0%Sold out
Amundi0$00.00%−1,060−100.0%Sold out
KBC Group NV0$00.00%−904−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−416−100.0%Sold out
CWM, LLC0$00.00%−137−100.0%Sold out
Comerica Bank0$00.00%−143−100.0%Sold out
Bogart Wealth, LLC0$00.00%−125−100.0%Sold out
Red Tortoise LLC0$00.00%−83−100.0%Sold out
Bell Investment Advisors, Inc0$00.00%−76−100.0%Sold out
Allworth Financial LP0$00.00%−7−100.0%Sold out
Decheng Capital Management III (Cayman), LLC––––Not filed